A Systematic Review on the Safety of Mycobacterium tuberculosis-Specific Antigen-Based Skin Tests for Tuberculosis Infection Compared With Tuberculin Skin Tests

Background: A systematic review showed that the accuracy of Mycobacterium tuberculosis antigen-based skin tests (TBSTs) for tuberculosis is similar to that of interferon γrelease assay, but the safety of TBSTs has not been systematically reviewed. Methods: We searched for studies reporting injection site reactions (ISRs) and systemic adverse events associated with TBSTs. We searched Medline, Embase, e-library, the Chinese Biomedical Literature Database, and the China National Knowledge Infrastructure database for studies through 30 July 2021, and the database search was updated until 22 November 2022. Results: We identified 7 studies for Cy-Tb (Serum Institute of India), 7 (including 2 found through the updated search) for C-TST (Anhui Zhifei Longcom), and 11 for Diaskintest (Generium). The pooled risk of any injection site reactions (ISRs) due to Cy-Tb (n = 2931; 5 studies) did not differ significantly from that for tuberculin skin tests (TSTs; risk ratio, 1.05 [95% confidence interval,. 70-1.58]). More than 95% of ISRs were reported as mild or moderate; common ISRs included pain, itching, and rash. In 1 randomized controlled study, 49 of 153 participants (37.6%) given Cy-Tb experience any systemic adverse event (eg, fever and headache), compared with 56 of 149 participants (37.6%) given TST (risk ratio, 0.85 [95% confidence interval,. 6-1.2]). In a randomized controlled study in China (n = 14 579), the frequency of systemic adverse events in participants given C-TST was similar to that for TST, and the frequency of ISRs was similar to or lower than that for TST. Reporting of the safety data on Diaskintest was not standardized, precluding meta-analysis. Conclusion: The safety profile of TBSTs appears similar to that of TSTs and is associated with mostly mild ISRs. © 2023 The Author(s). Published by Oxford University Press on behalf of Infectious Diseases Society of America.

Authors
Hamada Y. , Kontsevaya I. , Surkova E. , Wang T.T. , Wan-Hsin L. , Matveev A. , Ziganshina L.E. , Denkinger C.M. , Korobitsyn A. , Ismail N. , Abubakar I. , Rangaka M.X.
Publisher
Oxford University Press
Number of issue
5
Language
English
Status
Published
Number
ofad228
Volume
10
Year
2023
Organizations
  • 1 Institute for Global Health, University College London, London, United Kingdom
  • 2 Division of Clinical Infectious Diseases, Research Center Borstel, Leibniz Lung Center, Borstel, Germany
  • 3 German Center for Infection Research (DZIF), Partner Site Hamburg- Lübeck-Borstel-Riems, Borstel, Germany
  • 4 Respiratory Medicine & International Health, University of Lübeck, Lübeck, Germany
  • 5 Department of Infectious Disease, Faculty of Medicine, Imperial College London, London, United Kingdom
  • 6 Royal Brompton and Harefield Hospitals, Part of Guy's and St Thomas' Nhs Foundation Trust London, London, United Kingdom
  • 7 Department of Pediatrics, Taipei Veterans General Hospital, Taipei, Taiwan
  • 8 Department of Clinical Pharmacology and Therapy Named after Acad. B. Ye. Votchal, Russian Medical Academy of Continuous Professional Education, Moscow, Russian Federation
  • 9 Russian Medical Academy for Continuing Professional Education of the Ministry of Health, Cochrane Russia, Centre for Knowledge Translation, Moscow, Russian Federation
  • 10 Department of Pharmacology, Kazan Medical University, Kazan, Russian Federation
  • 11 Department of General and Clinical Pharmacology, Rudn University, Moscow, Russian Federation
  • 12 Division of Tropical Medicine, Centre of Infectious Disease, Heidelberg University Hospital, Heidelberg, Germany
  • 13 German Center of Infection Research, Partner Site Heidelberg University Hospital, Heidelberg, Germany
  • 14 Unit for Prevention, Diagnosis, Treatment, Care and Innovation, Global Tuberculosis Programme, World Health Organization, Geneva, Switzerland
  • 15 Division of Epidemiology and Biostatistics & CIDRI-AFRICA, University of Cape Town, Cape Town, South Africa
Keywords
diagnostics classification description; IGRA; LTBI; skin tests; TST

Other records